Four biotech takeover targets?
at Investor's Business Daily - Fri Aug 29, 5:58PM CDT
Following the news that Roche (RHHBY) is acquiring InterMune (ITMN) for $8.3 bil, other takeover talk has started to stir, leading to speculation that Achillion Pharmaceuticals (ACHN), Intercept Pharmaceuticals (ICPT), Puma Biotechnology (PBYI) and...
Top Performing Sector ETFs of August - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Aug 29, 1:00PM CDT
Few sector ETFs have performed exceptionally well this month and are leading the market higher.
4 Biotechs That Might Be Bought Soon
at Investor's Business Daily - Fri Aug 29, 10:53AM CDT
The recent announcement that Roche (RHHBY) will buy InterMune (ITMN) for $8.3 billion brought new life to M&A speculation in the biotech industry, which had been relatively neglected as the buzz focused on tax-inversion deals by biopharmaceutical...
Acquisitions, Appointment, and Vaccine Recommendations - Research Reports on InterMune, Amgen, Johnson & Johnson, Merck and Medtronic
PR Newswire - Thu Aug 28, 8:30AM CDT
Today, Analysts Review released its research reports regarding InterMune Inc. (NASDAQ: ITMN), Amgen, Inc. (NASDAQ: AMGN), Johnson & Johnson (NYSE: JNJ), Merck & Co., Inc. (NYSE: MRK) and Medtronic, Inc. (NYSE: MDT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6042-100free.
InterMune Stockholders Encouraged to Contact Securities Law Firm about Takeover
PR Newswire - Wed Aug 27, 4:13PM CDT
Securities lawyers at Dunnam & Dunnam are investigating the board of InterMune (NASDAQ: ITMN) in connection with a buyout for only $74 per share. Concerned ITMN investors are encouraged to contact attorney Hamilton Lindley by clicking here.
INTERMUNE SHAREHOLDER ALERT - InterMune, Inc.: The Law Offices of Vincent Wong Investigates the Sale of InterMune, Inc. to Roche Holding AG
Business Wire - Wed Aug 27, 3:26PM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of InterMune, Inc. (Nasdaq:ITMN) ("InterMune"
Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Aug 27, 9:32AM CDT
Roche's agreement to acquire InterMune has raised hopes for more such deals in the biotech sector.
INTERMUNE INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating the Board of Directors of InterMune, Inc. (ITMN) in Relation to the Proposed Sale of the Company to Roche Holdings, Inc.
Business Wire - Wed Aug 27, 9:21AM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of InterMune, Inc. ("InterMune" or the "Company"
Roche, InterMune a Strategic Play in Midst of Inversions
at The Street - Wed Aug 27, 8:19AM CDT
As more companies seek tax savings through inversions, strategic reasons still remain for drug company deals.
INVESTOR ALERT - InterMune, Inc.: The Law Offices of Vincent Wong Investigates the Sale of InterMune, Inc. to Roche Holding AG
Business Wire - Tue Aug 26, 5:58PM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of InterMune, Inc. (Nasdaq:ITMN) ("InterMune"
Roche Furthers Immunotherapy Program with SP142 Launch - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 5:22PM CDT
Roche (RHHBY) announced that Spring Bioscience, a member of the Roche Group, has launched its PD-L1 (SP142) rabbit monoclonal immunohistochemistry (IHC) antibody1.
Celgene, Gilead Lead Big Biotech Stock Movers
at Investor's Business Daily - Tue Aug 26, 4:55PM CDT
Big-cap biotechs moved in strong volume on the stock market today as Deutsche Bank added several to its short-term buy list, after Citi reported back from visits with medical experts. Celgene (CELG) hit a new high above 95 after Deutsche Bank analyst...
Stocks Rise As Biotechs Lead; Amazon To Buy Twitch
at Investor's Business Daily - Tue Aug 26, 3:58PM CDT
Stocks were moderately higher Monday with biotech stocks leading the way. The Nasdaq and the Dow Jones industrial average rose 0.4% and the S&P 500 gained 0.5%. After the close, Amazon (AMZN) announced it was paying $970 million to buy Twitch, a live...
INTERMUNE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - Tue Aug 26, 12:36PM CDT
Rigrodsky & Long, P.A.:
Biotech ETFs Surge on InterMune-Roche Deal - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Aug 26, 12:00PM CDT
The news of InterMune's acquisition by Roche has led to a rally in the biotech ETFs space.
Why InterMune (ITMN) Stock Is Gaining Today
at The Street - Tue Aug 26, 11:14AM CDT
InterMune (ITMN) shares are up on heavy trading, one day after the company agreed to be bought by Roche for $8.3 billion.
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of InterMune, Inc. and Its Board of Directors In Connection With the Sale of the Company to Roche Holding AG -- ITMN
PR Newswire - Tue Aug 26, 10:35AM CDT
Levi & Korsinsky is investigating the Board of Directors of InterMune, Inc. ("InterMune" or the "Company"
3 Biotechs Surging Following InterMune Takeover - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 10:07AM CDT
InterMune 's (ITMN) impending acquisition by Roche (RHHBY) caused many mid-cap biotechs to rise.